Drug Profile
Alendronate/calcitriol - Yuyu Pharma
Alternative Names: MaxmarvilLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Yuyu
- Class Antihyperglycaemics; Bisphosphonates; Calcium regulators; Cholestenes; Osteoporosis therapies; Small molecules; Sterols; Vitamin D analogues
- Mechanism of Action Osteoclast inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Osteoporosis
Most Recent Events
- 12 Feb 2019 Chemical structure information added
- 01 Jan 2012 Launched for Osteoporosis in Thailand (PO)
- 01 Jan 2004 Launched for Osteoporosis in South Korea (PO)